Recall Record

Irvine, CA, United States

Medtronic Neurosurgery recalls

10 recalls recorded since 2018, most recently on 17 June 2026. 8 are listed as ongoing. Status and classification are as published by the FDA.

Recalls10
Ongoing (FDA)8
Terminated or completed2
Class I (FDA)2

Ongoing Class II Medical devices

Recall started
17 June 2026
Reason
Ventriculostomy devices, used during ventriculostomy procedures to gain access to the ventricular system, may exhibit endotoxin levels that exceed the acceptable limit for devices that come into contact with cerebrospinal fluid; endotoxin exposure can cause an acute inflammatory process.
Distribution
Worldwide - US Nationwide distribution in the states of UT, AL, CA, NC, GA, AR, LA, KY, LA, KY, IL, OK and the country of Costa Rica.
Initiated
Voluntary: Firm initiated
Recall number
Z-2768-2026

Ongoing Class I Medical devices

Recall started
1 November 2024
Reason
Due to complaints received reporting cracks and/or leaks of the stopcocks associated with the external drainage and monitoring system (EDMS).
Distribution
Worldwide distribution. US nationwide including Puerto Rico; Algeria, Argentina, Australia, Austria, Bahrain, Barbados, Bosnia And Herzegovina, Brunei Darussalam, Cambodia, Canada, Chile, China, Colombia, Costa Rica, Curacao, Cyprus, Czech Republic, Denmark, Dominican Republic, Egypt, Finland, Fren
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0662-2025, Z-0661-2025

Ongoing Class I Medical devices

Recall started
22 January 2024
Reason
Potential for catheter disconnection from the patient line stopcock connectors.
Distribution
Worldwide Distribution: US (nationwide): AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV; and OUS (foreign): Argentina, Australia, Bahrain, Belgium,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1162-2024, Z-1163-2024, Z-1166-2024, Z-1165-2024, Z-1164-2024

Ongoing Class II Medical devices

Recall started
28 June 2023
Reason
Product labeling contains incorrect expiration date
Distribution
US Nationwide distribution in the states of NJ, FL, CA, IL.
Initiated
Voluntary: Firm initiated
Recall number
Z-2412-2023

Ongoing Class II Medical devices

Recall started
13 June 2023
Reason
Dura regeneration matrix may have out-of-specification endotoxin levels due to issues with in-process and finished goods endotoxin testing, which may present clinically with signs and symptoms of an acute inflammatory process, comparable to infection.
Distribution
Worldwide - US Nationwide distribution including in the states of PR, TX, WA, HI, MI, GA, AL, IL, IN, IA, MO, KY, NY, CA, AZ, PA, UT, ME, MD, MN, FL, AK, NE, VA, OR, WI, NC, LA, SD, TN, MS, DE, NJ, ID, SC, OH, MA, DC, NM, WV, NH, CT, NV, OK, AR, KS, MT, RI, CO, ND, WY, VT and the countries of Barbad
Initiated
Voluntary: Firm initiated
Recall number
Z-2207-2023

Ongoing Class II Medical devices

Recall started
11 January 2021
Reason
Potential for variation in radiopaque marking visibility under radiographic imaging for adjustable and fixed-pressure valves that are used in the management of hydrocephalus
Distribution
Worldwide distribution. US nationwide, Albania, Algeria, Argentina, Armenia, Australia, Austria, Bahrain, Bangladesh, Belgium, Plurinational State Of Bolivia, Bosnia And Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Canada, Canary Islands, Cayman Islands, Chile, C
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1116-2021, Z-1117-2021, Z-1115-2021

Ongoing Class II Medical devices

Recall started
16 December 2020
Reason
Neonatal Valves were manufactured with a ventricular catheter connection site shorter than the design specification. The defect can lead to difficulty in securing the valve to the proximal catheter which could result in disconnection of the ventricular catheter from the valve and shunt malfunction
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, AZ, CA, CO, FL, GA, IL, KS, KY, LA, MA, MI, MO, NV, NM, NY, ND, OH, OK, TN, VA and the countries of Albania, Australia, Brazil, Cyprus, Ireland, Mexico, Qatar, Romania, Russian Federation, Serbia, South Africa, Spain,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0872-2021, Z-0873-2021, Z-0871-2021

Ongoing Class II Medical devices

Recall started
8 December 2020
Reason
There is a potential for a defect on the seal of the outer pouch of catheters. The defect may compromise the sterility of the pouch contents, which may increase the risk of post-operative infection, requiring further medical intervention.
Distribution
Worldwide Distribution. US nationwide, Albania, Argentina, Armenia, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Egypt, Finland, Germany, Greece, Guam, Hong Kong, Hungary, India, Islamic Republic of Iran, Ire
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0740-2021, Z-0738-2021, Z-0739-2021

Terminated Class II Medical devices

Recall started
3 May 2018
Terminated
30 August 2022
Reason
The packaging sterile barrier does not comply with the applicable packaging standard for terminally sterilized medical devices. While the Instructions for Use (IFU) state Do not use if package has been previously opened or damaged , it is possible that the seal breach may go undetected by the user's naked eye.
Distribution
Domestic: AL, AZ, AR, CA, CO, DC, FL, GA, ID, IL, IN, IA, KS, LA, MD, MI, MN, MS, MO, NB, NV, NJ, NY, NC, ND, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WV, WI, and WY OUS: Australia, Germany, Kenya, Russian Federation, South Africa
Initiated
Voluntary: Firm initiated
Recall number
Z-3212-2018

Terminated Class II Medical devices

Recall started
20 December 2017
Terminated
8 December 2023
Reason
Medtronic is initiating a voluntary recall because the products identified above did not adequately demonstrate acceptable packaging performance to current standards.
Distribution
Algeria, Armenia, Australia, Canada, Cyprus, Egypt, Germany, Ghana, Greece, Guam, Iceland, Indonesia, Iran, Italy, Jordan, New Zealand, Poland, Portugal, Puerto Rica, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Swaziland, Sweden, Switzerland, Syria, Tunisia, Turkey, UAE, UK, US
Initiated
Voluntary: Firm initiated
Recall number
Z-0622-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.